About this Course
The course will cover medications commonly used to treat psychiatric disorders found in the DSM-V as well as briefly touch on procedures such as TMS, ketamine infusions, stellate ganglion blocks, vagal nerve stimulation and ECT. The material will broadly cover antidepressants, antipsychotics, mood stabilizers, stimulants, sedative-hypnotics, anxiolytics, and drugs used for the treatment of substance abuse, highlighting the basic mechanism of action, FDA and off label indications, common adverse side effects as well basic cautions in matters of pregnancy, lactation and interactions with OTC medications, herbs, and foods. The course will also include information on drugs such as metformin and semaglutide that are now being used to address weight gain associated with psychiatric disorders and psychotropic medications. Further we will cover the short and long term effects of recreational drugs of abuse, such as cannabis and alcohol, on medications that have recently been released on the market, such as zuranolone now approved for post-partum depression, and medications currently undergoing human trials for FDA approval, such as MDMA for PTSD. There will also be a section on nutritional and integrative psychiatry, examining the role of diet and exploring the value of such supplementation as l-methyl folate, omega 3 fatty acids, and N-acetyl cysteine in mental health.
-
2 CE available for LCPC, LCSW, and clinical psychologists
Learning Objectives
Participants will be able to....
-
distinguish which antidepressants have a higher risk of weight gain and daytime sedation
-
differentiate between serotonin discontinuation and serotonin syndrome
-
identify the difference between akathisia, which can be a side effect of medications like fluoxetine, and anxiety
-
detect dystonia and pseudo-Parkinsonism
Instructor(s)
Robert Marseilles
MD
Help your practice thrive, starting today
Thanks to our CE Sponsors
Keep in touch for future offerings!
Add your email to the mailing list to get the latest updates.